Benchmark Initiates Applied DNA Sciences With Speculative Buy

By: via Benzinga
Analysts at Benchmark initiated coverage on Applied DNA Sciences Inc (NASDAQ: APDN) with a Speculative Buy rating. The target price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.